|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.00 GBX | +3.95% |
|
+8.22% | +36.21% |
| 06-25 | EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities | AN |
| 06-25 | Avacta Therapeutics Reaches Study Design Terms With US FDA for Salivary Gland Cancer Therapy | MT |
| Market Cap | 370M 488M 429M 395M 693M 46.05B 708M 4.76B 1.84B 22.74B 1.83B 1.79B 79.01B | P/E 2026 * |
-11.8x | P/E 2027 * | -11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 397M 524M 460M 424M 744M 49.41B 760M 5.1B 1.97B 24.39B 1.97B 1.92B 84.76B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
98.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Avacta Group Plc
| 24-12-10 | Deutsche Bank Upgrades Avacta Group to Hold | MT |
| 24-12-10 | RBC raises Hikma; JPMorgan cuts Schroders | AN |
| 24-09-17 | Deutsche Bank Downgrades Avacta Group to Sell | MT |
| 24-09-17 | Berenberg, Peel cut TT Electronics to 'hold' | AN |
| 24-06-19 | Deutsche Raises Avacta to Hold from Sell | MT |
| 1 day | +3.95% | ||
| 1 week | +8.22% | ||
| 1 month | +1.80% | ||
| 3 months | +15.33% | ||
| 6 months | +50.48% | ||
| Current year | +36.21% |
| 1 week | 68.75 |  | 82 |
| 1 month | 66.9 | | 82 |
| Current year | 48 | | 92 |
| 1 year | 28 | | 92 |
| 3 years | 26 | | 166.98 |
| 5 years | 26 | | 189.94 |
| 10 years | 13 | | 291.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2024-03-31 | |
Brian Hahn
DFI | Director of Finance/CFO | 51 | 2025-01-21 |
| Chief Tech/Sci/R&D Officer | - | 2026-02-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Fry
BRD | Director/Board Member | 60 | 2020-02-02 |
Mark Goldberg
BRD | Director/Board Member | 71 | 2021-08-16 |
| Director/Board Member | 56 | 2022-03-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-09-01 | Fiscal year | Chief Financial Officer | 500,000 | 0.1393% | ||
| 24-09-01 | Free | Chief Executive Officer | 3,600,000 | 1.0027% | ||
| 24-09-01 | Sell | Chief Financial Officer | 500,000 | 0.1393% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.95% | +8.22% | +159.02% | -35.77% | 489M | |
| +0.33% | +1.37% | +64.03% | +119.11% | 55.63B | |
| +0.82% | +15.05% | +79.93% | +84.34% | 52.25B | |
| +1.36% | +0.36% | -14.06% | -14.69% | 23.07B | |
| -1.04% | +7.91% | +1.61% | +419.24% | 22.41B | |
| -0.18% | +7.20% | +32.16% | -14.07% | 17.32B | |
| -1.10% | +4.00% | +28.70% | -34.51% | 15.94B | |
| -3.35% | +8.96% | +132.20% | +290.18% | 13.47B | |
| +2.89% | +5.51% | +27.11% | +181.45% | 13.77B | |
| +1.31% | +0.53% | +28.62% | - | 12.43B | |
| Average | +0.50% | +5.12% | +53.93% | +110.58% | 22.68B | |
| Weighted average by Cap. | +0.27% | +5.14% | +48.74% | +119.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -30.5M -40.26M -35.34M -32.59M -57.15M -3.8B -58.36M -392M -152M -1.87B -151M -148M -6.51B | - |
| Net Debt | 26.93M 35.56M 31.21M 28.78M 50.47M 3.35B 51.54M 346M 134M 1.66B 133M 131M 5.75B | 27.15M 35.85M 31.47M 29.02M 50.88M 3.38B 51.96M 349M 135M 1.67B 134M 132M 5.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | GBX 79.00 | +3.95% | 3,162,459 |
| 26-06-25 | GBX 76.00 | +4.83% | 2,753,318 |
| 26-06-24 | GBX 72.50 | +0.42% | 850,895 |
| 26-06-23 | GBX 72.20 | +0.28% | 1,327,870 |
| 26-06-22 | GBX 72.00 | -1.37% | 1,707,444 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AVCT Stock
Select your edition
All financial news and data tailored to specific country editions
